English

INTERLEUKIN GENETICS INC

EDGAR

ILIU Quarterly report (10-Q) · filed 2017-05-11

100 filing records in this dataset, filed from 1998-03-31 to 2017-05-11. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

196 thousand USD

2017 Q1 · USD

Exact inputs and evidence

Revenue: 196444 USD Source

Operating margin

-1,177.22%

2017 Q1 · %

Exact inputs and evidence

Operating Income: -2312576 USD Source
Revenue: 196444 USD Source

Operating cash flow

-1.49 million USD

2017 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -1487305 USD Source

Free cash flow

-1.49 million USD

2017 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -1487305 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 791 thousand USD 2017-03-31 Source
Exact value

790737 USD
Long-term debt including current maturities: Not available
Shares outstanding: 229 million shares 2017-03-31 Source
Exact value

229435726 shares

Reported share-count change

32.66% · 56.5 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

172953440 shares · 2016-03-31· Source
229435726 shares · 2017-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

1.75 million USD

2016-04-01 – 2017-03-31

Exact inputs and evidence

Revenue: 590209 USD · 2016-04-01 – 2016-06-30 Source
Revenue: 734468 USD · 2016-07-01 – 2016-09-30 Source
Revenue: 2513456 USD · 2016-01-01 – 2016-12-31 Source
Revenue: 2285595 USD · 2016-01-01 – 2016-09-30 Source
Revenue: 196444 USD · 2017-01-01 – 2017-03-31 Source

Net income

6.39 million USD

2016-04-01 – 2017-03-31

Exact inputs and evidence

Net income: -2087201 USD · 2016-04-01 – 2016-06-30 Source
Net income: -1966505 USD · 2016-07-01 – 2016-09-30 Source
Net income: 7400000 USD · 2016-01-01 – 2016-12-31 Source
Net income: -5571442 USD · 2016-01-01 – 2016-09-30 Source
Net income: -2529710 USD · 2017-01-01 – 2017-03-31 Source

Operating cash flow

-6.22 million USD

2016-04-01 – 2017-03-31

Exact inputs and evidence

Operating cash flow: -2929820 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -1808184 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -5126452 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -2929820 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -6542604 USD · 2016-01-01 – 2016-12-31 Source
Operating cash flow: -5126452 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -1487305 USD · 2017-01-01 – 2017-03-31 Source

Capital expenditure

75.9 thousand USD

2016-04-01 – 2017-03-31

Exact inputs and evidence

Capital expenditure: 8963 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 8963 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 54526 USD · 2016-01-01 – 2016-09-30 Source
Capital expenditure: 8963 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 84863 USD · 2016-01-01 – 2016-12-31 Source
Capital expenditure: 54526 USD · 2016-01-01 – 2016-09-30 Source
Capital expenditure: 0 USD · 2017-01-01 – 2017-03-31 Source

Free cash flow

-6.3 million USD

2016-04-01 – 2017-03-31

Exact inputs and evidence

Operating cash flow: -2929820 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -1808184 USD · 2016-01-01 – 2016-03-31 Source
Operating cash flow: -5126452 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -2929820 USD · 2016-01-01 – 2016-06-30 Source
Operating cash flow: -6542604 USD · 2016-01-01 – 2016-12-31 Source
Operating cash flow: -5126452 USD · 2016-01-01 – 2016-09-30 Source
Operating cash flow: -1487305 USD · 2017-01-01 – 2017-03-31 Source
Capital expenditure: 8963 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 8963 USD · 2016-01-01 – 2016-03-31 Source
Capital expenditure: 54526 USD · 2016-01-01 – 2016-09-30 Source
Capital expenditure: 8963 USD · 2016-01-01 – 2016-06-30 Source
Capital expenditure: 84863 USD · 2016-01-01 – 2016-12-31 Source
Capital expenditure: 54526 USD · 2016-01-01 – 2016-09-30 Source
Capital expenditure: 0 USD · 2017-01-01 – 2017-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2017-05-11.

Financial data available through: 2016-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2016-12-31
Operating income: 11 of 11 periods available· newest 2016-12-31
Net income: 11 of 11 periods available· newest 2016-12-31
Operating cash flow: 11 of 11 periods available· newest 2016-12-31
Capital expenditure: 11 of 11 periods available· newest 2016-12-31
Total assets: 11 of 11 periods available· newest 2016-12-31
Total liabilities: 11 of 11 periods available· newest 2016-12-31
Current assets: 11 of 11 periods available· newest 2016-12-31
Current liabilities: 11 of 11 periods available· newest 2016-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2016-12-31
long term debt: No compatible figures in this window
Shares outstanding: 7 of 11 periods available· newest 2016-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+74.4%

Prior period

USD 1.44 million

2015-01-01 – 2015-12-31
Current period

USD 2.51 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

2513456 − 1440910 = 1072546 USD

1440910 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
2513456 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · INTERLEUKIN GENETICS INC · 2016-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Year-over-year change in Revenue: 1072546 USD Concept: fundies:Revenue Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 2513456 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417020895/iliu-20161231.xml#200335 Filing: 000114420417020895 Input fundies:Revenue: 1440910 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417020895/iliu-20161231.xml#200463 Filing: 000114420417020895
The citation records this snapshot. The page link may show a newer release later.
Net income
-6.3%

Prior period

USD 7.9 million

2015-01-01 – 2015-12-31
Current period

USD 7.4 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

7400000 − 7900000 = -500000 USD

7900000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
7400000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · INTERLEUKIN GENETICS INC · 2016-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Year-over-year change in Net income: -500000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 7400000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417026502/iliu-20170331.xml#623100 Filing: 000114420417026502 Input fundies:NetIncome: 7900000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417026502/iliu-20170331.xml#623239 Filing: 000114420417026502
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 148,555

Prior period

−USD 6.69 million

2015-01-01 – 2015-12-31
Current period

−USD 6.54 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

-6542604 − -6691159 = 148555 USD

-6691159 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
-6542604 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · INTERLEUKIN GENETICS INC · 2016-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Year-over-year change in Operating cash flow: 148555 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -6542604 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417020895/iliu-20161231.xml#186063 Filing: 000114420417020895 Input fundies:OperatingCashFlow: -6691159 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417020895/iliu-20161231.xml#186300 Filing: 000114420417020895
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+2.9%

Prior period

USD 82,489

2015-01-01 – 2015-12-31
Current period

USD 84,863

2016-01-01 – 2016-12-31

Exact inputs and evidence

84863 − 82489 = 2374 USD

82489 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
84863 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · INTERLEUKIN GENETICS INC · 2016-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Year-over-year change in Capital expenditure: 2374 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 84863 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417020895/iliu-20161231.xml#186537 Filing: 000114420417020895 Input fundies:CapitalExpenditure: 82489 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417020895/iliu-20161231.xml#186731 Filing: 000114420417020895
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2016 2016-01-01 – 2016-12-31

Revenue USD 2.51 million 100% of revenue
Cost of revenue USD 1.6 million 64% of revenue
Operating expenses USD 7.59 million 302% of revenue
Operating income −USD 6.67 million −266% of revenue
Tax, interest and other Derived −USD 14.07 million −560% of revenue
Net income USD 7.4 million 294% of revenue

Cash

Operating cash flow −USD 6.54 million −260% of revenue
Capital expenditure USD 84,863 3.4% of revenue
Free cash flow Derived −USD 6.63 million −264% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2007 Operating loss: operating costs were 310% of revenue.
2008 Operating loss: operating costs were 354% of revenue.
2009 Operating loss: operating costs were 937% of revenue.
2010 Operating loss: operating costs were 420% of revenue.
2011 Net loss: net income was −176% of revenue.
2012 Operating loss: operating costs were 309% of revenue.
2013 Operating loss: operating costs were 372% of revenue.
2014 Operating loss: operating costs were 450% of revenue.
2015 Operating loss: operating costs were 606% of revenue.
2016 Operating loss: operating costs were 366% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2007 2007-01-01 – 2007-12-31	2827284	8773703 Derived	-5946419	272366 Derived	-6218785	-2577471 Derived	Source 2007-01-01 – 2007-12-31: 2827284 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -5946419 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -6218785 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -2538649 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 38822 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	2620687	9273433 Derived	-6652746	-1361 Derived	-6651385	-5758482 Derived	Source 2008-01-01 – 2008-12-31: 2620687 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -6652746 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -6651385 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -5565754 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 192728 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	1078430	10108126 Derived	-9029696	1522707 Derived	-10552403	-7262335 Derived	Source 2009-01-01 – 2009-12-31: 1078430 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -9029696 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: -10552403 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: -6548332 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 714003 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	1940190	8143795 Derived	-6203605	-217315 Derived	-5986290	-5835670 Derived	Source 2010-01-01 – 2010-12-31: 1940190 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -6203605 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -5986290 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -5740261 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 95409 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	2857105	-2142895 Derived	5000000	10025182 Derived	-5025182	-4503762 Derived	Source 2011-01-01 – 2011-12-31: 2857105 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: 5000000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -5025182 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -4499344 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 4418 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	2236387	6906475 Derived	-4670088	-9770088 Derived	5100000	-4546738 Derived	Source 2012-01-01 – 2012-12-31: 2236387 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -4670088 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: 5100000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -4541738 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 5000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	2429612	9028138 Derived	-6598526	-13698526 Derived	7100000	-4812467 Derived	Source 2013-01-01 – 2013-12-31: 2429612 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -6598526 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: 7100000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -3974771 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 837696 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	1810318	8139717 Derived	-6329399	-12629399 Derived	6300000	-5825583 Derived	Source 2014-01-01 – 2014-12-31: 1810318 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -6329399 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: 6300000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -5727550 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 98033 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	1440910	8729481 Derived	-7288571	-15188571 Derived	7900000	-6773648 Derived	Source 2015-01-01 – 2015-12-31: 1440910 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -7288571 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: 7900000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -6691159 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 82489 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	2513456	9187036 Derived	-6673580	-14073580 Derived	7400000	-6627467 Derived	Source 2016-01-01 – 2016-12-31: 2513456 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -6673580 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: 7400000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -6542604 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 84863 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 2.5M 2016

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-12-31	Revenue	2827284	Revenue: 2827284 Open source
20082008-12-31	Revenue	2620687	Revenue: 2620687 Open source
20092009-12-31	Revenue	1078430	Revenue: 1078430 Open source
20102010-12-31	Revenue	1940190	Revenue: 1940190 Open source
20112011-12-31	Revenue	2857105	Revenue: 2857105 Open source
20122012-12-31	Revenue	2236387	Revenue: 2236387 Open source
20132013-12-31	Revenue	2429612	Revenue: 2429612 Open source
20142014-12-31	Revenue	1810318	Revenue: 1810318 Open source
20152015-12-31	Revenue	1440910	Revenue: 1440910 Open source
20162016-12-31	Revenue	2513456	Revenue: 2513456 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

74.4% 2016

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20072007-12-31	Year over year	-40.2%	Revenue: 2827284 Open source Revenue: 4731026 Open source
20082008-12-31	Year over year	-7.3%	Revenue: 2620687 Open source Revenue: 2827284 Open source
20092009-12-31	Year over year	-58.8%	Revenue: 1078430 Open source Revenue: 2620687 Open source
20102010-12-31	Year over year	79.9%	Revenue: 1940190 Open source Revenue: 1078430 Open source
20112011-12-31	Year over year	47.3%	Revenue: 2857105 Open source Revenue: 1940190 Open source
20122012-12-31	Year over year	-21.7%	Revenue: 2236387 Open source Revenue: 2857105 Open source
20132013-12-31	Year over year	8.6%	Revenue: 2429612 Open source Revenue: 2236387 Open source
20142014-12-31	Year over year	-25.5%	Revenue: 1810318 Open source Revenue: 2429612 Open source
20152015-12-31	Year over year	-20.4%	Revenue: 1440910 Open source Revenue: 1810318 Open source
20162016-12-31	Year over year	74.4%	Revenue: 2513456 Open source Revenue: 1440910 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -265.5% 2016

Net margin 294.4% 2016

Free cash flow margin -263.7% 2016

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20072007-12-31	Operating margin	-210.3%	Operating Income: -5946419 Open source Revenue: 2827284 Open source
20082008-12-31	Operating margin	-253.9%	Operating Income: -6652746 Open source Revenue: 2620687 Open source
20092009-12-31	Operating margin	-837.3%	Operating Income: -9029696 Open source Revenue: 1078430 Open source
20102010-12-31	Operating margin	-319.7%	Operating Income: -6203605 Open source Revenue: 1940190 Open source
20112011-12-31	Operating margin	175%	Operating Income: 5000000 Open source Revenue: 2857105 Open source
20122012-12-31	Operating margin	-208.8%	Operating Income: -4670088 Open source Revenue: 2236387 Open source
20132013-12-31	Operating margin	-271.6%	Operating Income: -6598526 Open source Revenue: 2429612 Open source
20142014-12-31	Operating margin	-349.6%	Operating Income: -6329399 Open source Revenue: 1810318 Open source
20152015-12-31	Operating margin	-505.8%	Operating Income: -7288571 Open source Revenue: 1440910 Open source
20162016-12-31	Operating margin	-265.5%	Operating Income: -6673580 Open source Revenue: 2513456 Open source
20072007-12-31	Net margin	-220%	Net Income: -6218785 Open source Revenue: 2827284 Open source
20082008-12-31	Net margin	-253.8%	Net Income: -6651385 Open source Revenue: 2620687 Open source
20092009-12-31	Net margin	-978.5%	Net Income: -10552403 Open source Revenue: 1078430 Open source
20102010-12-31	Net margin	-308.5%	Net Income: -5986290 Open source Revenue: 1940190 Open source
20112011-12-31	Net margin	-175.9%	Net Income: -5025182 Open source Revenue: 2857105 Open source
20122012-12-31	Net margin	228%	Net Income: 5100000 Open source Revenue: 2236387 Open source
20132013-12-31	Net margin	292.2%	Net Income: 7100000 Open source Revenue: 2429612 Open source
20142014-12-31	Net margin	348%	Net Income: 6300000 Open source Revenue: 1810318 Open source
20152015-12-31	Net margin	548.3%	Net Income: 7900000 Open source Revenue: 1440910 Open source
20162016-12-31	Net margin	294.4%	Net Income: 7400000 Open source Revenue: 2513456 Open source
20072007-12-31	Free cash flow margin	-91.2%	Revenue: 2827284 Open source Operating Cash Flow: -2538649 Open source Capital Expenditure: 38822 Open source
20082008-12-31	Free cash flow margin	-219.7%	Revenue: 2620687 Open source Operating Cash Flow: -5565754 Open source Capital Expenditure: 192728 Open source
20092009-12-31	Free cash flow margin	-673.4%	Revenue: 1078430 Open source Operating Cash Flow: -6548332 Open source Capital Expenditure: 714003 Open source
20102010-12-31	Free cash flow margin	-300.8%	Revenue: 1940190 Open source Operating Cash Flow: -5740261 Open source Capital Expenditure: 95409 Open source
20112011-12-31	Free cash flow margin	-157.6%	Revenue: 2857105 Open source Operating Cash Flow: -4499344 Open source Capital Expenditure: 4418 Open source
20122012-12-31	Free cash flow margin	-203.3%	Revenue: 2236387 Open source Operating Cash Flow: -4541738 Open source Capital Expenditure: 5000 Open source
20132013-12-31	Free cash flow margin	-198.1%	Revenue: 2429612 Open source Operating Cash Flow: -3974771 Open source Capital Expenditure: 837696 Open source
20142014-12-31	Free cash flow margin	-321.8%	Revenue: 1810318 Open source Operating Cash Flow: -5727550 Open source Capital Expenditure: 98033 Open source
20152015-12-31	Free cash flow margin	-470.1%	Revenue: 1440910 Open source Operating Cash Flow: -6691159 Open source Capital Expenditure: 82489 Open source
20162016-12-31	Free cash flow margin	-263.7%	Revenue: 2513456 Open source Operating Cash Flow: -6542604 Open source Capital Expenditure: 84863 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -6.5M 2016

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-12-31	Operating cash flow	-2538649	Operating Cash Flow: -2538649 Open source
20082008-12-31	Operating cash flow	-5565754	Operating Cash Flow: -5565754 Open source
20092009-12-31	Operating cash flow	-6548332	Operating Cash Flow: -6548332 Open source
20102010-12-31	Operating cash flow	-5740261	Operating Cash Flow: -5740261 Open source
20112011-12-31	Operating cash flow	-4499344	Operating Cash Flow: -4499344 Open source
20122012-12-31	Operating cash flow	-4541738	Operating Cash Flow: -4541738 Open source
20132013-12-31	Operating cash flow	-3974771	Operating Cash Flow: -3974771 Open source
20142014-12-31	Operating cash flow	-5727550	Operating Cash Flow: -5727550 Open source
20152015-12-31	Operating cash flow	-6691159	Operating Cash Flow: -6691159 Open source
20162016-12-31	Operating cash flow	-6542604	Operating Cash Flow: -6542604 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -6.6M 2016

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-12-31	Free cash flow	-2577471	Operating Cash Flow: -2538649 Open source Capital Expenditure: 38822 Open source
20082008-12-31	Free cash flow	-5758482	Operating Cash Flow: -5565754 Open source Capital Expenditure: 192728 Open source
20092009-12-31	Free cash flow	-7262335	Operating Cash Flow: -6548332 Open source Capital Expenditure: 714003 Open source
20102010-12-31	Free cash flow	-5835670	Operating Cash Flow: -5740261 Open source Capital Expenditure: 95409 Open source
20112011-12-31	Free cash flow	-4503762	Operating Cash Flow: -4499344 Open source Capital Expenditure: 4418 Open source
20122012-12-31	Free cash flow	-4546738	Operating Cash Flow: -4541738 Open source Capital Expenditure: 5000 Open source
20132013-12-31	Free cash flow	-4812467	Operating Cash Flow: -3974771 Open source Capital Expenditure: 837696 Open source
20142014-12-31	Free cash flow	-5825583	Operating Cash Flow: -5727550 Open source Capital Expenditure: 98033 Open source
20152015-12-31	Free cash flow	-6773648	Operating Cash Flow: -6691159 Open source Capital Expenditure: 82489 Open source
20162016-12-31	Free cash flow	-6627467	Operating Cash Flow: -6542604 Open source Capital Expenditure: 84863 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

174.2% 2016

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20072007-12-31	Liabilities / assets	37.8%	Total Liabilities: 6193535 Open source Total Assets: 16385949 Open source
20082008-12-31	Liabilities / assets	63.1%	Total Liabilities: 7671961 Open source Total Assets: 12154388 Open source
20092009-12-31	Liabilities / assets	287.8%	Total Liabilities: 8834091 Open source Total Assets: 3069463 Open source
20102010-12-31	Liabilities / assets	211.4%	Total Liabilities: 12633096 Open source Total Assets: 5975000 Open source
20112011-12-31	Liabilities / assets	486.8%	Total Liabilities: 14376748 Open source Total Assets: 2953517 Open source
20122012-12-31	Liabilities / assets	559.4%	Total Liabilities: 16589446 Open source Total Assets: 2965646 Open source
20132013-12-31	Liabilities / assets	48.1%	Total Liabilities: 4871833 Open source Total Assets: 10125055 Open source
20142014-12-31	Liabilities / assets	66%	Total Liabilities: 8750264 Open source Total Assets: 13267121 Open source
20152015-12-31	Liabilities / assets	137.9%	Total Liabilities: 8952920 Open source Total Assets: 6491520 Open source
20162016-12-31	Liabilities / assets	174.2%	Total Liabilities: 6681322 Open source Total Assets: 3835772 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.59× 2016

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20072007-12-31	Current assets / current liabilities	1.62×	Current Assets: 10012508 Open source Current Liabilities: 6162535 Open source
20082008-12-31	Current assets / current liabilities	1.87×	Current Assets: 6866284 Open source Current Liabilities: 3666961 Open source
20092009-12-31	Current assets / current liabilities	0.72×	Current Assets: 1315991 Open source Current Liabilities: 1834091 Open source
20102010-12-31	Current assets / current liabilities	2.91×	Current Assets: 4752790 Open source Current Liabilities: 1633096 Open source
20112011-12-31	Current assets / current liabilities	0.15×	Current Assets: 2111921 Open source Current Liabilities: 14376748 Open source
20122012-12-31	Current assets / current liabilities	1.06×	Current Assets: 2401568 Open source Current Liabilities: 2273191 Open source
20132013-12-31	Current assets / current liabilities	1.84×	Current Assets: 8952583 Open source Current Liabilities: 4871833 Open source
20142014-12-31	Current assets / current liabilities	3.04×	Current Assets: 12180658 Open source Current Liabilities: 4011650 Open source
20152015-12-31	Current assets / current liabilities	1.04×	Current Assets: 5695533 Open source Current Liabilities: 5477936 Open source
20162016-12-31	Current assets / current liabilities	0.59×	Current Assets: 3271150 Open source Current Liabilities: 5551228 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2007 2007-01-01 – 2007-12-31	−USD 6.22 million Exact value Exact value: -6218785 USD 2007-01-01 – 2007-12-31: -6218785 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERLEUKIN GENETICS INC · 2007-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Net Income: -6218785 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6218785 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/0001144204-10-015632.txt#9253 The citation records this snapshot. The page link may show a newer release later.	−USD 2.54 million Exact value Exact value: -2538649 USD 2007-01-01 – 2007-12-31: -2538649 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERLEUKIN GENETICS INC · 2007-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Operating Cash Flow: -2538649 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2538649 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/0001144204-10-015632.txt#9631 The citation records this snapshot. The page link may show a newer release later.	USD 38,822 Exact value Exact value: 38822 USD 2007-01-01 – 2007-12-31: 38822 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERLEUKIN GENETICS INC · 2007-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Capital Expenditure: 38822 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 38822 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/0001047469-09-003095.txt#6580 The citation records this snapshot. The page link may show a newer release later.	−USD 2.58 million Calculation and evidence -2538649 − 38822 USD Exact free cash flow: -2577471 USD 2007-01-01 – 2007-12-31: -2538649 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 38822 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERLEUKIN GENETICS INC · 2007-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Free cash flow: -2577471 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -2538649 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/0001144204-10-015632.txt#9631 Input fundies:CapitalExpenditure: 38822 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/0001047469-09-003095.txt#6580 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 6.65 million Exact value Exact value: -6651385 USD 2008-01-01 – 2008-12-31: -6651385 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERLEUKIN GENETICS INC · 2008-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Net Income: -6651385 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6651385 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/0001144204-10-015632.txt#9253 The citation records this snapshot. The page link may show a newer release later.	−USD 5.57 million Exact value Exact value: -5565754 USD 2008-01-01 – 2008-12-31: -5565754 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERLEUKIN GENETICS INC · 2008-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Operating Cash Flow: -5565754 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5565754 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/0001144204-10-015632.txt#9631 The citation records this snapshot. The page link may show a newer release later.	USD 192,728 Exact value Exact value: 192728 USD 2008-01-01 – 2008-12-31: 192728 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERLEUKIN GENETICS INC · 2008-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Capital Expenditure: 192728 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 192728 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/0001047469-09-003095.txt#6580 The citation records this snapshot. The page link may show a newer release later.	−USD 5.76 million Calculation and evidence -5565754 − 192728 USD Exact free cash flow: -5758482 USD 2008-01-01 – 2008-12-31: -5565754 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 192728 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERLEUKIN GENETICS INC · 2008-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Free cash flow: -5758482 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5565754 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/0001144204-10-015632.txt#9631 Input fundies:CapitalExpenditure: 192728 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/0001047469-09-003095.txt#6580 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	−USD 10.55 million Exact value Exact value: -10552403 USD 2009-01-01 – 2009-12-31: -10552403 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERLEUKIN GENETICS INC · 2009-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Net Income: -10552403 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10552403 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/0001144204-11-016841.txt#4838 The citation records this snapshot. The page link may show a newer release later.	−USD 6.55 million Exact value Exact value: -6548332 USD 2009-01-01 – 2009-12-31: -6548332 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERLEUKIN GENETICS INC · 2009-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Operating Cash Flow: -6548332 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6548332 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/0001144204-11-016841.txt#5054 The citation records this snapshot. The page link may show a newer release later.	USD 714,003 Exact value Exact value: 714003 USD 2009-01-01 – 2009-12-31: 714003 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERLEUKIN GENETICS INC · 2009-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Capital Expenditure: 714003 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 714003 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/0001144204-11-016841.txt#5078 The citation records this snapshot. The page link may show a newer release later.	−USD 7.26 million Calculation and evidence -6548332 − 714003 USD Exact free cash flow: -7262335 USD 2009-01-01 – 2009-12-31: -6548332 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 714003 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERLEUKIN GENETICS INC · 2009-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Free cash flow: -7262335 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6548332 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/0001144204-11-016841.txt#5054 Input fundies:CapitalExpenditure: 714003 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/0001144204-11-016841.txt#5078 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	−USD 5.99 million Exact value Exact value: -5986290 USD 2010-01-01 – 2010-12-31: -5986290 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERLEUKIN GENETICS INC · 2010-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Net Income: -5986290 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5986290 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420412018063/iliu-20111231.xml#20261 Filing: 000114420412018063 The citation records this snapshot. The page link may show a newer release later.	−USD 5.74 million Exact value Exact value: -5740261 USD 2010-01-01 – 2010-12-31: -5740261 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERLEUKIN GENETICS INC · 2010-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Operating Cash Flow: -5740261 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5740261 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420412018063/iliu-20111231.xml#18464 Filing: 000114420412018063 The citation records this snapshot. The page link may show a newer release later.	USD 95,409 Exact value Exact value: 95409 USD 2010-01-01 – 2010-12-31: 95409 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERLEUKIN GENETICS INC · 2010-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Capital Expenditure: 95409 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 95409 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420412018063/iliu-20111231.xml#22256 Filing: 000114420412018063 The citation records this snapshot. The page link may show a newer release later.	−USD 5.84 million Calculation and evidence -5740261 − 95409 USD Exact free cash flow: -5835670 USD 2010-01-01 – 2010-12-31: -5740261 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 95409 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERLEUKIN GENETICS INC · 2010-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Free cash flow: -5835670 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5740261 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420412018063/iliu-20111231.xml#18464 Filing: 000114420412018063 Input fundies:CapitalExpenditure: 95409 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420412018063/iliu-20111231.xml#22256 Filing: 000114420412018063 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 5.03 million Exact value Exact value: -5025182 USD 2011-01-01 – 2011-12-31: -5025182 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERLEUKIN GENETICS INC · 2011-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Net Income: -5025182 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -5025182 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420413018280/iliu-20121231.xml#85286 Filing: 000114420413018280 The citation records this snapshot. The page link may show a newer release later.	−USD 4.5 million Exact value Exact value: -4499344 USD 2011-01-01 – 2011-12-31: -4499344 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERLEUKIN GENETICS INC · 2011-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Operating Cash Flow: -4499344 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4499344 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420413018280/iliu-20121231.xml#102059 Filing: 000114420413018280 The citation records this snapshot. The page link may show a newer release later.	USD 4,418 Exact value Exact value: 4418 USD 2011-01-01 – 2011-12-31: 4418 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERLEUKIN GENETICS INC · 2011-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Capital Expenditure: 4418 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4418 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420413018280/iliu-20121231.xml#102415 Filing: 000114420413018280 The citation records this snapshot. The page link may show a newer release later.	−USD 4.5 million Calculation and evidence -4499344 − 4418 USD Exact free cash flow: -4503762 USD 2011-01-01 – 2011-12-31: -4499344 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 4418 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERLEUKIN GENETICS INC · 2011-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Free cash flow: -4503762 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4499344 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420413018280/iliu-20121231.xml#102059 Filing: 000114420413018280 Input fundies:CapitalExpenditure: 4418 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420413018280/iliu-20121231.xml#102415 Filing: 000114420413018280 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	USD 5.1 million Exact value Exact value: 5100000 USD 2012-01-01 – 2012-12-31: 5100000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERLEUKIN GENETICS INC · 2012-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Net Income: 5100000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5100000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420414067815/iliu-20140930.xml#468223 Filing: 000114420414067815 The citation records this snapshot. The page link may show a newer release later.	−USD 4.54 million Exact value Exact value: -4541738 USD 2012-01-01 – 2012-12-31: -4541738 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERLEUKIN GENETICS INC · 2012-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Operating Cash Flow: -4541738 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4541738 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420414016879/iliu-20131231.xml#121975 Filing: 000114420414016879 The citation records this snapshot. The page link may show a newer release later.	USD 5,000 Exact value Exact value: 5000 USD 2012-01-01 – 2012-12-31: 5000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERLEUKIN GENETICS INC · 2012-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Capital Expenditure: 5000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 5000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420414016879/iliu-20131231.xml#122369 Filing: 000114420414016879 The citation records this snapshot. The page link may show a newer release later.	−USD 4.55 million Calculation and evidence -4541738 − 5000 USD Exact free cash flow: -4546738 USD 2012-01-01 – 2012-12-31: -4541738 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 5000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERLEUKIN GENETICS INC · 2012-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Free cash flow: -4546738 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4541738 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420414016879/iliu-20131231.xml#121975 Filing: 000114420414016879 Input fundies:CapitalExpenditure: 5000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420414016879/iliu-20131231.xml#122369 Filing: 000114420414016879 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	USD 7.1 million Exact value Exact value: 7100000 USD 2013-01-01 – 2013-12-31: 7100000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERLEUKIN GENETICS INC · 2013-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Net Income: 7100000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: 7100000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420415049138/iliu-20150630.xml#177926 Filing: 000114420415049138 The citation records this snapshot. The page link may show a newer release later.	−USD 3.97 million Exact value Exact value: -3974771 USD 2013-01-01 – 2013-12-31: -3974771 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERLEUKIN GENETICS INC · 2013-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Operating Cash Flow: -3974771 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -3974771 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420415017319/iliu-20141231.xml#820215 Filing: 000114420415017319 The citation records this snapshot. The page link may show a newer release later.	USD 837,696 Exact value Exact value: 837696 USD 2013-01-01 – 2013-12-31: 837696 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERLEUKIN GENETICS INC · 2013-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Capital Expenditure: 837696 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 837696 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420415017319/iliu-20141231.xml#820609 Filing: 000114420415017319 The citation records this snapshot. The page link may show a newer release later.	−USD 4.81 million Calculation and evidence -3974771 − 837696 USD Exact free cash flow: -4812467 USD 2013-01-01 – 2013-12-31: -3974771 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 837696 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERLEUKIN GENETICS INC · 2013-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Free cash flow: -4812467 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -3974771 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420415017319/iliu-20141231.xml#820215 Filing: 000114420415017319 Input fundies:CapitalExpenditure: 837696 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420415017319/iliu-20141231.xml#820609 Filing: 000114420415017319 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	USD 6.3 million Exact value Exact value: 6300000 USD 2014-01-01 – 2014-12-31: 6300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERLEUKIN GENETICS INC · 2014-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Net Income: 6300000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: 6300000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420416134133/iliu-20160930.xml#133008 Filing: 000114420416134133 The citation records this snapshot. The page link may show a newer release later.	−USD 5.73 million Exact value Exact value: -5727550 USD 2014-01-01 – 2014-12-31: -5727550 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERLEUKIN GENETICS INC · 2014-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Operating Cash Flow: -5727550 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5727550 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420416088456/iliu-20151231.xml#122064 Filing: 000114420416088456 The citation records this snapshot. The page link may show a newer release later.	USD 98,033 Exact value Exact value: 98033 USD 2014-01-01 – 2014-12-31: 98033 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERLEUKIN GENETICS INC · 2014-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Capital Expenditure: 98033 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 98033 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420416088456/iliu-20151231.xml#122495 Filing: 000114420416088456 The citation records this snapshot. The page link may show a newer release later.	−USD 5.83 million Calculation and evidence -5727550 − 98033 USD Exact free cash flow: -5825583 USD 2014-01-01 – 2014-12-31: -5727550 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 98033 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERLEUKIN GENETICS INC · 2014-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Free cash flow: -5825583 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5727550 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420416088456/iliu-20151231.xml#122064 Filing: 000114420416088456 Input fundies:CapitalExpenditure: 98033 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420416088456/iliu-20151231.xml#122495 Filing: 000114420416088456 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	USD 7.9 million Exact value Exact value: 7900000 USD 2015-01-01 – 2015-12-31: 7900000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERLEUKIN GENETICS INC · 2015-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Net Income: 7900000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: 7900000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417026502/iliu-20170331.xml#623239 Filing: 000114420417026502 The citation records this snapshot. The page link may show a newer release later.	−USD 6.69 million Exact value Exact value: -6691159 USD 2015-01-01 – 2015-12-31: -6691159 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERLEUKIN GENETICS INC · 2015-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Operating Cash Flow: -6691159 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6691159 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417020895/iliu-20161231.xml#186300 Filing: 000114420417020895 The citation records this snapshot. The page link may show a newer release later.	USD 82,489 Exact value Exact value: 82489 USD 2015-01-01 – 2015-12-31: 82489 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERLEUKIN GENETICS INC · 2015-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Capital Expenditure: 82489 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 82489 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417020895/iliu-20161231.xml#186731 Filing: 000114420417020895 The citation records this snapshot. The page link may show a newer release later.	−USD 6.77 million Calculation and evidence -6691159 − 82489 USD Exact free cash flow: -6773648 USD 2015-01-01 – 2015-12-31: -6691159 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 82489 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERLEUKIN GENETICS INC · 2015-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Free cash flow: -6773648 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6691159 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417020895/iliu-20161231.xml#186300 Filing: 000114420417020895 Input fundies:CapitalExpenditure: 82489 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417020895/iliu-20161231.xml#186731 Filing: 000114420417020895 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	USD 7.4 million Exact value Exact value: 7400000 USD 2016-01-01 – 2016-12-31: 7400000 USD Inspect Net Income Open source Share or cite Citation for Net Income · INTERLEUKIN GENETICS INC · 2016-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Net Income: 7400000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: 7400000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417026502/iliu-20170331.xml#623100 Filing: 000114420417026502 The citation records this snapshot. The page link may show a newer release later.	−USD 6.54 million Exact value Exact value: -6542604 USD 2016-01-01 – 2016-12-31: -6542604 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · INTERLEUKIN GENETICS INC · 2016-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Operating Cash Flow: -6542604 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6542604 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417020895/iliu-20161231.xml#186063 Filing: 000114420417020895 The citation records this snapshot. The page link may show a newer release later.	USD 84,863 Exact value Exact value: 84863 USD 2016-01-01 – 2016-12-31: 84863 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · INTERLEUKIN GENETICS INC · 2016-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Capital Expenditure: 84863 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 84863 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417020895/iliu-20161231.xml#186537 Filing: 000114420417020895 The citation records this snapshot. The page link may show a newer release later.	−USD 6.63 million Calculation and evidence -6542604 − 84863 USD Exact free cash flow: -6627467 USD 2016-01-01 – 2016-12-31: -6542604 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 84863 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · INTERLEUKIN GENETICS INC · 2016-12-31 INTERLEUKIN GENETICS INC (edgar:1037649) Free cash flow: -6627467 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T18:20:29Z Snapshot: 8972d51dbced7677488b6d96e7118a31ff750baffa0007a69862ee6f83c81394 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1037649?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -6542604 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417020895/iliu-20161231.xml#186063 Filing: 000114420417020895 Input fundies:CapitalExpenditure: 84863 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1037649/000114420417020895/iliu-20161231.xml#186537 Filing: 000114420417020895 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

100 filings · 1,862 latest values · 1,862 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001037649, 1037649, ILIU, edgar:1037649

Also known as INTERLEUKIN GENETICS INC, MEDICAL SCIENCE SYSTEMS INC

INTERLEUKIN GENETICS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2016 2016-01-01 – 2016-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation